Skip to main content
TipRanks
Go Ultimate75% OFF

OncoArendi Therapeutics SA (1B1) Q4 2024 Earnings Report

0 Followers

DE:1B1 Q4 2024 EPS Results

Actual EPS
-EUR 0.12
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-EUR 0.23

DE:1B1 Q4 2024 Revenue Results

Actual Revenue
EUR 0
Expected Revenue
EUR 339.12K
Beat/Miss
Missed by -EUR 339.12K
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q4 2024
Date
03/31/2025
Time
TBA
Conference Call
Monday, March 31, 2025
DE:1B1 Upcoming Earnings

OncoArendi Therapeutics SA's next earnings date is estimated for April 6, 2027, based on past reporting schedules.

Q4 2024 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2024 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:1B1 Earnings History

DE:1B1 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Apr 06, 20272026 (Q4)―--0.02――
Oct 30, 20262026 (Q3)―--0.06―
Sep 30, 20262026 (Q2)―-0.02-0.0443.53% (+0.02)
Apr 30, 20262026 (Q1)―--0.06―
Mar 31, 20262025 (Q4)―-0.02-0.1283.78% (+0.10)
Oct 31, 20252025 (Q3)―--0.08―
Sep 30, 20252025 (Q2)―-0.04-0.162.96% (+0.07)
Apr 30, 20252025 (Q1)―--0.09―
Mar 31, 20252024 (Q4)―-0.12-0.2348.30% (+0.11)
Oct 15, 20242024 (Q3)―-0.08-0.06-48.80% (-0.03)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed